Danaher (DHR)
(Delayed Data from NYSE)
$272.63 USD
-3.80 (-1.37%)
Updated Sep 20, 2024 04:02 PM ET
After-Market: $272.86 +0.23 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Danaher Corporation [DHR]
Reports for Purchase
Showing records 121 - 140 ( 508 total )
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Environmental & Applied Spin; Musings on Multiple Expansion Potential
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 91122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Life Sciences: COVID Era Concluding - Mapping Company Exposure
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 82122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Beats 2Q Estimates, COVID De-Risked, Bioprocess Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
2Q Preview - Mapping COVID Sales; 2023 Visibility Increasing
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Provider: Zacks Investment Research
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Danaher Corporation
Industry: Diversified Operations
Optimized Entry and Exit Levels for DHR 61122
Provider: Stock Traders Daily
Analyst: Research Department